- Home
- WKSP vs APLT Comparison
WKSP vs APLT Comparison
Compare WKSP & APLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WKSP | APLT |
|---|---|---|
| Founded | 2003 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 17.2M | 18.0M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | WKSP | APLT |
|---|---|---|
| Price | $2.24 | $0.10 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 2 | 2 |
| Target Price | ★ $9.25 | $1.25 |
| AVG Volume (30 Days) | 250.3K | ★ 10.7M |
| Earning Date | 11-13-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $14,286,679.00 | $1,000,000.00 |
| Revenue This Year | $142.95 | $124.18 |
| Revenue Next Year | $109.62 | $66.67 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 123.37 | N/A |
| 52 Week Low | $1.92 | $0.09 |
| 52 Week High | $12.00 | $1.50 |
Technical Indicators
Market Signals| Indicator | WKSP | APLT |
|---|---|---|
| Relative Strength Index (RSI) | 46.27 | 27.74 |
| Support Level | $2.10 | $0.10 |
| Resistance Level | $2.42 | $0.12 |
| Average True Range (ATR) | 0.18 | 0.01 |
| MACD | -0.01 | 0.02 |
| Stochastic Oscillator | 25.82 | 31.58 |
Price Performance
Historical ComparisonAbout WKSP Worksport Ltd.
Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.